OpenScience.ink

1 week ago • Integrative medicine research

Chinese herbal medicine versus liraglutide for weight loss in adults with obesity over 12 monthsComparative effectiveness of Chinese herbal medicine versus liraglutide for weight loss in adults with obesity: A 12-month real-world target trial emulation study.

📖 Top 50% Journal

1 week ago • International journal of cardiology. Cardiovascular risk and prevention

Comparing combined GLP-1 and SGLT2 treatments to GLP-1 alone for heart rhythm issues in non-diabetic obese patients over timeCombination GLP-1 receptor agonist and SGLT2 inhibitor therapy versus GLP-1 receptor agonist monotherapy on arrhythmia outcomes in non-diabetic obese patients: A real-world time-dependent analysis.

📖 Top 30% Journal

2 weeks ago • Journal of food and drug analysis

Can semaglutide affect tumor markers? Evidence from a patient caseCan semaglutide influence tumor biomarkers? Insight from a clinical case.

📖 Top 30% Journal

2 weeks ago • Stem cell reviews and reports

How GLP-1-like Drugs and Stem Cells Connect Metabolism and Tissue RepairGLP1 Mimetics and Stem Cells: An Intersection of Metabolic and Regenerative Medicine.

📖 Top 20% Journal

2 weeks ago • Oral surgery, oral medicine, oral pathology and oral radiology

Mouth and face side effects linked to diabetes drugs called GLP-1 receptor agonists: a global real-world studyOrofacial adverse events associated with Glucagon-like peptide-1 receptor agonists: a real-world multinational retrospective matched cohort study.

📖 Top 50% Journal

3 weeks ago • Cardiovascular toxicology

Incretin-Based Treatments and Their Role in Heart Damage Caused by Doxorubicin: A Review of GLP-1 and Combined GIP/GLP-1 TherapiesIncretin-Based Therapies in Doxorubicin-Induced Cardiotoxicity: A Systematic Review of GLP-1 and Dual GIP/GLP-1 Agonists.

📖 Top 30% Journal

3 weeks ago • Skin appendage disorders

Using GLP-1 Receptor Agonists to Treat Hidradenitis Suppurativa and Overall Patient HealthGLP-1 Receptor Agonists in Hidradenitis Suppurativa: Time to Treat the Whole Patient.

📖 Top 50% Journal

3 weeks ago • Endocrine journal

Tirzepatide use in older adults with type 2 diabetes and its links to low blood sugar risk and weight lossReal-world clinical outcomes of tirzepatide administration in older patients with type 2 diabetes, with a focus on the risk of hypoglycemia and weight loss-related parameters.

📖 Top 30% Journal

3 weeks ago • High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension

Comparing heart disease risk estimates for Orforglipron using two prediction modelsExploratory Cardiovascular Risk Modeling of Orforglipron Using the PREVENT Equations Compared with the Pooled Cohort Equations: A Post-Hoc Analysis from a Systematic Review and Meta-analysis.

📖 Top 20% Journal

3 weeks ago • Laryngoscope investigative otolaryngology

Heart Protection by GLP-1 Agonists in People with Sleep Apnea and Their Heart RiskCardio-Protective Effect of GLP-1 Agonists in OSA Patients: A Study of Cardiovascular Risk.

📖 Top 30% Journal

3 weeks ago • Pharmaceutical development and technology

Temperature-Responsive Gels for Slow Semaglutide Release to Break Weight Loss Plateaus in Obese RatsThermosensitive hydrogels for sustained semaglutide release: overcoming weight loss plateau in diet-induced obese rats.

📖 Top 50% Journal

3 weeks ago • Endocrine connections

Use of GLP-1 Receptor Drugs Around Conception and Risk of Major Birth Defects: A Review and AnalysisPericonceptional use of GLP-1 receptor agonists and the risk of major congenital malformations: a systematic review and meta-analysis.

📖 Top 20% Journal

3 weeks ago • JBRA assisted reproduction

What We Know About How GLP-1 Receptor Agonists Affect FertilityGLP-1 Receptor Agonists and Fertility: What Is Known So Far?

📖 Top 50% Journal

3 weeks ago • Annals of gastroenterology

How GLP-1 receptor drugs affect upper digestive tract exam results: a review and combined analysisEffect of GLP-1 receptor agonists on upper gastrointestinal endoscopy outcomes: a systematic review and meta-analysis.

📖 Top 30% Journal

3 weeks ago • Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society

How Non-Experts Influence Online Conversations About Mounjaro on Twitter (X)Influence without medical expertise: a social network analysis of Mounjaro discussions on twitter (X).

📖 Top 30% Journal

3 weeks ago • American journal of cardiovascular drugs : drugs, devices, and other interventions

Combined Treatment with GLP-1 Receptor Agonists and SGLT2 Inhibitors in Patients with Heart Failure: Review and Analysis of Observational StudiesCombination Therapy of GLP-1 RA and SGLT2i in Patients with Established Heart Failure: A Systematic Review and Meta-Analysis of Observational Studies.

📖 Top 20% Journal

3 weeks ago • BMC cardiovascular disorders

Tirzepatide and the risk of new aortic valve narrowing in people with obesityTirzepatide and risk of newly diagnosed aortic stenosis in patients with obesity: a multi-institutional real-world cohort study.

📖 Top 30% Journal

3 weeks ago • BMC ophthalmology

Partially reversible sudden vision loss in both eyes and blocked small retinal artery after semaglutide use: a case reportPartially reversible bilateral non-arteritic anterior ischemic optic neuropathy and branch retinal artery occlusion following semaglutide use. a case report.

📖 Top 30% Journal

3 weeks ago • Otolaryngologic clinics of North America

How Obesity and Weight Loss Relate to Nose and Allergy HealthObesity, Weight Loss, and Rhinology and Allergy.

📖 Top 50% Journal

3 weeks ago • Journal of Ayurveda and integrative medicine

The anti-diabetic effects of the herbal mix Varanadi Kashayam may involve boosting GLP-1 hormone and blocking DPP4 enzymeThe systemic anti-diabetic effect of polyherbal formulation Varanadi Kashayam is mediated through GLP-1 secretion and DPP4 inhibition.

📖 Top 50% Journal

4 weeks ago • Digestive diseases and sciences

Stomach Side Effects and Healthcare Use in Patients Taking Glucagon-Like Peptide-1 Medicines: A Real-World StudyIncidence of Gastrointestinal Adverse Events and Healthcare Resource Utilization in Patients Using Glucagon-Like Peptide-1 Analogs: A Real-World Study.

📖 Top 20% Journal

4 weeks ago • ACR open rheumatology

Autoimmune Disease Risk Linked to Different Diabetes Treatments: GLP-1RA, DPP-4i, and SGLT2iAutoimmune Disease Risk With GLP-1RA, DPP-4i, and SGLT2i Treatment in Patients With Diabetes.

📖 Top 20% Journal

1 month ago • Gastro hep advances

Glucagon-Like Peptide-1 Receptor Agonists and Pain Relief in Long-Term PancreatitisThe Effect of Glucagon-Like Peptide-1 Receptor Agonists on Pain Management in Chronic Pancreatitis: A Real-World Cohort Study.

📖 Top 50% Journal

1 month ago • Gastro hep advances

Glucagon-Like Peptide-1 Receptor Drugs and Their Role in Inflammatory Bowel DiseaseGlucagon-Like Peptide-1 Receptor Agonists in Inflammatory Bowel Disease: A Narrative Review.

📖 Top 50% Journal

1 month ago • The journal of allergy and clinical immunology. Global

📖 Top 20% Journal

5 days ago • Biologie aujourd'hui

A History of GLP-1 and GIP Hormones: From Body Signals to Versatile Medicines[An historical overview of GLP-1/GIP incretins. From hormone to "swiss-army knife" medications].

Historical Article

1 week ago • Case reports in neurology

Nerve Weakness Causing Foot Drop Linked to Leg Crossing After Weight Loss with TirzepatideWeight Drop-Foot Drop: A Case Series of Peroneal Nerve Palsy from Leg Crossing after Tirzepatide-Mediated Weight Loss.

Case Reports

5 days ago • Endocrine

Timing of GLP-1 receptor agonist treatment in pregnancy-related high blood pressure disordersHypertensive disorders of pregnancy and GLP-1 receptor agonist timing: a systematic review and meta-analysis.

Systematic Review

2 days ago • Internal medicine (Tokyo, Japan)

Unusual Anorexia Nervosa After Weight-Loss Surgery and Diabetes Medication in a Patient with Severe Obesity and Type 2 DiabetesAtypical Anorexia Nervosa Developed in a Patient with Severe Obesity and Type 2 Diabetes Following Sleeve Gastrectomy and Postoperative Treatment with Semaglutide and Tirzepatide.

Article

4 days ago • Indian journal of endocrinology and metabolism

Whey protein before breakfast may reduce blood sugar spikes and increase insulin response in type 2 diabetesEffect of Pre-breakfast Whey Protein Supplement on Post-breakfast Glycaemic Excursion and Insulinotropic Response in Type 2 Diabetes Mellitus.

📖 Top 50% JournalArticle

← prevpage 10 of 15next →

GLP-1 Therapies Research Papers